Concepedia

G. Mani Subramanian

GM

Statistics

Publications

138

Citations

24.9K

H-Index

68

Active since

2003

Affiliations

Gilead Sciences (United States)(Current)

Clinical Research Institute

Human Genome Sciences (United States)

Texas Liver Institute

The University of Texas at San Antonio Health Science Center

G. Mani Subramanian is an author at Gilead Sciences (United States) specializing in viral hepatitis, antiviral therapy, and pharmacotherapy.

ORCID

Publications per year

2003–2024

138

Publications

138

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Eric Lawitz, Alessandra Mangia, David Wyles et al. · New England Journal of Medicine · 2013 · 1.8K citations

, , +17

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin, Edward Gane, Nezam H. Afdhal et al. · The Lancet · 2012 · 1.8K citations

, , +16

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

, , +17

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson et al. · New England Journal of Medicine · 2014 · 1.3K citations

, , +12

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text

, , +13

1–5 of 138